ClinicalTrials.Veeva

Menu

Evaluating Chronic Obstructive Pulmonary Disease (COPD) Patients' Treatment Compliance and Quality of Life Via Telemedicine

A

Ankara Etlik City Hospital

Status

Completed

Conditions

Copd
Telehealth

Treatments

Procedure: Telemedicine

Study type

Interventional

Funder types

Other

Identifiers

NCT06477328
GAZISOLMAZ01

Details and patient eligibility

About

The Covid-19 pandemic has disrupted the follow-up and treatment processes for patients, and telemedicine has emerged as an important alternative method. Our aim was to test compare COPD Assessment Test (CAT) scores, inhaler treatment techniques and adherence between telemedicine-mediated healthcare and healthcare provided face-to-face.

Enrollment

74 patients

Sex

All

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who were diagnosed with COPD according to Global Initiative for Obstructive Lung Disease (GOLD)
  • GOLD spirometric grade 3-4
  • At least one hospital admission in the past year
  • Acceptable score on the Mini-Mental State Examination
  • Residing in Ankara
  • Patient or caregiver must understand the process and be able to provide clear information
  • Medical records and laboratory test results must be accessible to healthcare professionals
  • Patient must have access to prescribed medications
  • Comorbidities outside of the lungs are included

Exclusion criteria

  • Patients diagnosed with asthma
  • Patients with lung cancer
  • Patients with combined pulmonary fibrosis and emphysema
  • Patients with active infections such as pneumonia or COVID-19
  • Patients being followed for COPD without spirometry
  • Patients with low cognitive function as determined by the Mini-Mental State Examination
  • Patients who do not consent to participate in the study
  • Patients lacking adequate social support
  • Patients with COPD grade 1-2
  • Patients with no hospital admissions in the past year
  • Patients diagnosed with psychotic disorders
  • Patients residing outside of Ankara
  • Patients enrolled in inpatient or supervised outpatient rehabilitation programs
  • Patients unable to use telemedicine devices or without a caregiver to assist
  • Patients and caregivers having difficulty providing information
  • Patients without internet access or video call capabilities at home

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

74 participants in 2 patient groups

Telemedicine group
Active Comparator group
Description:
The study participants were evaluated through telemedicine visits at specific intervals after the baseline visit, with the following schedule: * 1st visit: At day 10 post-baseline * 2nd visit: At the end of the 1st month * 3rd visit: At the end of the 3rd month These visits were conducted by the principal investigator using telemedicine. Additional telemedicine visits were arranged for patients in the telemedicine group as required.
Treatment:
Procedure: Telemedicine
Control group
No Intervention group
Description:
The visits for the control group, due to being conducted face-to-face in the outpatient clinic, were carried out by the routine attending physician at the clinic, who was not aware of the study. As suggested in the discharge recommendations during the baseline visit (0th visit) for the control group, they were advised to return for a follow-up visit on the 10th day and to schedule these follow-up appointments through the hospital's system. No intervention was made to facilitate the scheduling of these appointments.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems